The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Kinetics of postoperative circulating cell-free DNA and impact on minimal residual disease detection rates in patients with resected stage I-III colorectal cancer.
 
Stacey A. Cohen
Consulting or Advisory Role - Association of Community Cancer Centers (ACCC); Bayer; Istari oncology; Kallyope; Pfizer; Taiho Oncology
Research Funding - Boston Biomedical (Inst); EMD Serono/Merck (Inst); Isofol Medical (Inst); Natera; Pfizer (Inst); Polaris (Inst)
Expert Testimony - helsell Fetterman; Robins Kaplan
 
Pashtoon Murtaza Kasi
Consulting or Advisory Role - Bayer; Boston Healthcare Associates; Daiichi Sankyo/Astra Zeneca; Delcath Systems; Eisai; Exact Sciences; Foundation Medicine; Inflecton Point Biomedical Advisors; Ipsen (Inst); Lilly; MSD Oncology; Natera; QED Therapeutics; Seagen; SERVIER; Taiho Oncology; Taiho Pharmaceutical (Inst); Tempus
Research Funding - Advanced Accelerator Applications (Inst); Boston Scientific (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Vasily N. Aushev
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Diana L. Hanna
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim
 
Gregory P. Botta
Honoraria - Natera
Consulting or Advisory Role - Natera
Speakers' Bureau - Natera
 
Saima Sharif
Research Funding - GlaxoSmithKline
 
Georgios I. Laliotis MD, PhD
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Vivek R. Sharma
Stock and Other Ownership Interests - Madrigal Pharmaceuticals
Honoraria - Alexion Pharmaceuticals; Biomarin; Genzyme; Kedrion Biopharma; Novo Nordisk; Takeda
Consulting or Advisory Role - FORMA Therapeutics; HEMA Biologics
Speakers' Bureau - Alexion Pharmaceuticals; Biomarin; Genzyme; Novo Nordisk
 
Ali Alqahtani
No Relationships to Disclose
 
Sreenivasa R Chandana
Consulting or Advisory Role - Amgen; AstraZeneca; Dicephera Pharmaceuticals, Inc.; E.R. Squibb Sons, LLC; Johnson & Johnson/Janssen; Lilly
Speakers' Bureau - Amgen; Eisai; IPSEN; JNJ; Novartis
Research Funding - Abbvie (Inst); Alexion Pharmaceuticals (Inst); Alexion Pharmaceuticals (Inst); Alexo Therapeutics (Inst); ArQule (Inst); Asana Biosciences (Inst); Ascentage Pharma (Inst); BeiGene (Inst); BMS (Inst); Cerulean Pharma (Inst); Constellation Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Dicerna (Inst); Formation Biologics (Inst); Forty Seven (Inst); Livzon (Inst); Loxo (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst); Symphony Evolution (Inst); TaiRx, Inc. (Inst)
 
Sandra Kang
No Relationships to Disclose
 
Sakti Chakrabarti
Speakers' Bureau - Natera
 
Bradley G. Somer
Consulting or Advisory Role - AstraZeneca; Athenex; Eisai; Exelixis; onc.AI; Pfizer/EMD Serono
Speakers' Bureau - Onclive/Targeted Oncology
 
Anup Kasi
Research Funding - Astellas Pharma (Inst); Bavarian Nordic (Inst); Cardiff Oncology (Inst); Cend Therapeutics (Inst); FibroGen (Inst); Geistlich Pharma (Inst); Halozyme (Inst); Novocure (Inst); Rafael Pharmaceuticals (Inst); TESARO (Inst)
Travel, Accommodations, Expenses - Halozyme; Rafael Pharmaceuticals
 
Farshid Dayyani
Employment - Roche (I)
Consulting or Advisory Role - Array BioPharma; Eisai; Exelixis; Genentech/Roche; QED Therapeutics; Signatera
Speakers' Bureau - Amgen; Deciphera; Eisai; Exelixis; Genentech/Roche; ipsen; Natera; SERVIER; Sirtex Medical
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech (Inst); Ipsen (Inst); Merck (Inst); Taiho Pharmaceutical (Inst)
 
Midhun Malla
Consulting or Advisory Role - AstraZeneca; Natera; QED therapeutics
 
Adham A Jurdi
Employment - Natera
Stock and Other Ownership Interests - Cardiff Oncology; natera
Speakers' Bureau - Natera
Travel, Accommodations, Expenses - Natera
 
Minetta C. Liu
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Eisai (Inst); Exact Sciences (Inst); Genomic Health (Inst); GRAIL (Inst); Menarini Silicon Biosystems (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Genomic Health; GRAIL; Menarini Silicon Biosystems; Merck; Natera; Pfizer
 
Alexey Aleshin
Employment - Natera; Natera
Leadership - Natera
Stock and Other Ownership Interests - Natera
Consulting or Advisory Role - Mission Bio; Mission Bio
Travel, Accommodations, Expenses - Natera
 
Scott Kopetz
Stock and Other Ownership Interests - Frontier Medicines; Iylon; Lutris; Navire; Xilis
Consulting or Advisory Role - Abbvie; Accademia Nazionale Di Medicina (ACCMED); Amal Therapeutics; Amgen; AstraZeneca/MedImmune; Bayer Health; Bicara Therapeutics; Black Diamond Therapeutics; Boehringer Ingelheim; Bristol-Myers Squibb/Medarex; Cardiff Oncology; Carina Biotech; CureTeq; EMD Serono; Endeavor BioMedicines; Flame Biosciences; Foundation Medicine; Frontier Medicines; Genentech; Genomic Health; Gilead Sciences; GlaxoSmithKline; HalioDx; Harbinger Oncology, Inc; Holy Stone Healthcare; Inivata; Ipsen; Iylon; Jacobio; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Lilly; Lutris; Merck; Mirati Therapeutics; NeoGenomics Laboratories; Novartis; Numab; Ono Pharmaceutical; Pfizer; Redx Pharma; Repare Therapeutics; Replimune; Servier; Taiho Pharmaceutical; Takeda; Tempus; Xilis; Zentalis
Research Funding - Amgen; Array BioPharma; Biocartis; Daiichi Sankyo; EMD Serono; Genentech/Roche; Guardant Health; Lilly; MedImmune; Novartis; Sanofi